Borrelia burgdorferi strain 25015

Characterization of outer surface protein A and vaccination against infection

Erol Fikrig, Stephen W Barthold, David H. Persing, Xin Sun, Fred S. Kantor, Richard A. Flavell

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Mice vaccinated with outer surface protein A (OspA) from Borrelia burgdorferi strain N40 are protected from challenge with an intradermal syringe inoculum of B. burgdorferi strains N40, B31, and CD16. Vaccination experiments were done to determine if protection extended to strains 297 and 25015. We now show that OspA-N40 immunized mice are protected against challenge with strain 297, isolated from the cerebrospinal fluid of a patient with neuroborreliosis, but not against challenge with strain 25015, isolated from a tick in Millbrook, NY. The OspA gene from strain 25015 was therefore cloned and sequenced. The deduced OspA-25015 protein sequence differs from OspA-N40 at 40 of 273 amino acids. Furthermore, mice vaccinated with rOspA-25015 are protected from challenge with strain 25015 but not against strain N40. The results extend the usefulness of OspA as a vaccine candidate, but indicate that OspA can vary among strains of B. burgdorferi and that vaccination of mice with OspA-N40 does not protect against intradermal challenge with an inoculum of 104 strain 25015 spirochetes.

Original languageEnglish (US)
Pages (from-to)2256-2260
Number of pages5
JournalJournal of Immunology
Volume148
Issue number7
StatePublished - Apr 1 1992
Externally publishedYes

Fingerprint

Borrelia burgdorferi
Vaccination
Infection
Spirochaetales
OspA protein
Syringes
Ticks
Cerebrospinal Fluid
Vaccines
Amino Acids

ASJC Scopus subject areas

  • Immunology

Cite this

Fikrig, E., Barthold, S. W., Persing, D. H., Sun, X., Kantor, F. S., & Flavell, R. A. (1992). Borrelia burgdorferi strain 25015: Characterization of outer surface protein A and vaccination against infection. Journal of Immunology, 148(7), 2256-2260.

Borrelia burgdorferi strain 25015 : Characterization of outer surface protein A and vaccination against infection. / Fikrig, Erol; Barthold, Stephen W; Persing, David H.; Sun, Xin; Kantor, Fred S.; Flavell, Richard A.

In: Journal of Immunology, Vol. 148, No. 7, 01.04.1992, p. 2256-2260.

Research output: Contribution to journalArticle

Fikrig, E, Barthold, SW, Persing, DH, Sun, X, Kantor, FS & Flavell, RA 1992, 'Borrelia burgdorferi strain 25015: Characterization of outer surface protein A and vaccination against infection', Journal of Immunology, vol. 148, no. 7, pp. 2256-2260.
Fikrig, Erol ; Barthold, Stephen W ; Persing, David H. ; Sun, Xin ; Kantor, Fred S. ; Flavell, Richard A. / Borrelia burgdorferi strain 25015 : Characterization of outer surface protein A and vaccination against infection. In: Journal of Immunology. 1992 ; Vol. 148, No. 7. pp. 2256-2260.
@article{3ef487e5a6fb40d992451e3605c2b46a,
title = "Borrelia burgdorferi strain 25015: Characterization of outer surface protein A and vaccination against infection",
abstract = "Mice vaccinated with outer surface protein A (OspA) from Borrelia burgdorferi strain N40 are protected from challenge with an intradermal syringe inoculum of B. burgdorferi strains N40, B31, and CD16. Vaccination experiments were done to determine if protection extended to strains 297 and 25015. We now show that OspA-N40 immunized mice are protected against challenge with strain 297, isolated from the cerebrospinal fluid of a patient with neuroborreliosis, but not against challenge with strain 25015, isolated from a tick in Millbrook, NY. The OspA gene from strain 25015 was therefore cloned and sequenced. The deduced OspA-25015 protein sequence differs from OspA-N40 at 40 of 273 amino acids. Furthermore, mice vaccinated with rOspA-25015 are protected from challenge with strain 25015 but not against strain N40. The results extend the usefulness of OspA as a vaccine candidate, but indicate that OspA can vary among strains of B. burgdorferi and that vaccination of mice with OspA-N40 does not protect against intradermal challenge with an inoculum of 104 strain 25015 spirochetes.",
author = "Erol Fikrig and Barthold, {Stephen W} and Persing, {David H.} and Xin Sun and Kantor, {Fred S.} and Flavell, {Richard A.}",
year = "1992",
month = "4",
day = "1",
language = "English (US)",
volume = "148",
pages = "2256--2260",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "7",

}

TY - JOUR

T1 - Borrelia burgdorferi strain 25015

T2 - Characterization of outer surface protein A and vaccination against infection

AU - Fikrig, Erol

AU - Barthold, Stephen W

AU - Persing, David H.

AU - Sun, Xin

AU - Kantor, Fred S.

AU - Flavell, Richard A.

PY - 1992/4/1

Y1 - 1992/4/1

N2 - Mice vaccinated with outer surface protein A (OspA) from Borrelia burgdorferi strain N40 are protected from challenge with an intradermal syringe inoculum of B. burgdorferi strains N40, B31, and CD16. Vaccination experiments were done to determine if protection extended to strains 297 and 25015. We now show that OspA-N40 immunized mice are protected against challenge with strain 297, isolated from the cerebrospinal fluid of a patient with neuroborreliosis, but not against challenge with strain 25015, isolated from a tick in Millbrook, NY. The OspA gene from strain 25015 was therefore cloned and sequenced. The deduced OspA-25015 protein sequence differs from OspA-N40 at 40 of 273 amino acids. Furthermore, mice vaccinated with rOspA-25015 are protected from challenge with strain 25015 but not against strain N40. The results extend the usefulness of OspA as a vaccine candidate, but indicate that OspA can vary among strains of B. burgdorferi and that vaccination of mice with OspA-N40 does not protect against intradermal challenge with an inoculum of 104 strain 25015 spirochetes.

AB - Mice vaccinated with outer surface protein A (OspA) from Borrelia burgdorferi strain N40 are protected from challenge with an intradermal syringe inoculum of B. burgdorferi strains N40, B31, and CD16. Vaccination experiments were done to determine if protection extended to strains 297 and 25015. We now show that OspA-N40 immunized mice are protected against challenge with strain 297, isolated from the cerebrospinal fluid of a patient with neuroborreliosis, but not against challenge with strain 25015, isolated from a tick in Millbrook, NY. The OspA gene from strain 25015 was therefore cloned and sequenced. The deduced OspA-25015 protein sequence differs from OspA-N40 at 40 of 273 amino acids. Furthermore, mice vaccinated with rOspA-25015 are protected from challenge with strain 25015 but not against strain N40. The results extend the usefulness of OspA as a vaccine candidate, but indicate that OspA can vary among strains of B. burgdorferi and that vaccination of mice with OspA-N40 does not protect against intradermal challenge with an inoculum of 104 strain 25015 spirochetes.

UR - http://www.scopus.com/inward/record.url?scp=0026608004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026608004&partnerID=8YFLogxK

M3 - Article

VL - 148

SP - 2256

EP - 2260

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 7

ER -